Teleflex (NYSE:TFX) Issues FY 2026 Earnings Guidance

Teleflex (NYSE:TFX) updated its FY 2026 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 6.900-7.200 for the period, compared to the consensus EPS estimate of 6.700. The company issued revenue guidance of $2.3 billion-$2.3 billion, compared to the consensus revenue estimate of $2.3 billion.

Teleflex Stock Performance

Shares of TFX traded down $4.39 during midday trading on Friday, reaching $134.50. The stock had a trading volume of 752,284 shares, compared to its average volume of 522,151. The firm has a market cap of $5.95 billion, a PE ratio of -5.78, a P/E/G ratio of 0.98 and a beta of 0.81. The firm has a 50 day simple moving average of $131.72 and a 200-day simple moving average of $122.54. Teleflex has a one year low of $100.18 and a one year high of $145.00. The company has a current ratio of 2.60, a quick ratio of 2.03 and a debt-to-equity ratio of 0.94.

Teleflex (NYSE:TFX) last issued its earnings results on Thursday, August 6th. The medical technology company reported $1.76 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.28 by $0.48. The business had revenue of $570.33 million during the quarter, compared to the consensus estimate of $559.59 million. Teleflex had a negative net margin of 39.67% and a positive return on equity of 11.93%. Teleflex’s revenue was up 28.9% on a year-over-year basis. During the same period last year, the business posted $3.73 EPS. Teleflex has set its FY 2026 guidance at 6.900-7.200 EPS. As a group, sell-side analysts anticipate that Teleflex will post 7.05 EPS for the current year.

Teleflex Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Friday, August 14th will be issued a dividend of $0.34 per share. The ex-dividend date of this dividend is Friday, August 14th. This represents a $1.36 annualized dividend and a yield of 1.0%. Teleflex’s dividend payout ratio (DPR) is currently -5.96%.

Analyst Upgrades and Downgrades

Several equities analysts have commented on TFX shares. Needham & Company LLC upped their price objective on shares of Teleflex from $147.00 to $159.00 and gave the company a “buy” rating in a report on Friday, July 31st. Raymond James Financial restated an “outperform” rating and set a $150.00 target price on shares of Teleflex in a research note on Friday, May 8th. Wells Fargo & Company lifted their target price on shares of Teleflex from $130.00 to $138.00 and gave the stock an “equal weight” rating in a report on Friday, May 8th. Truist Financial reiterated a “hold” rating and issued a $143.00 price target (up from $135.00) on shares of Teleflex in a research note on Monday, May 11th. Finally, Bank of America upgraded shares of Teleflex from an “underperform” rating to a “neutral” rating and set a $135.00 price objective for the company in a research report on Monday, April 13th. One research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $149.80.

Key Headlines Impacting Teleflex

Here are the key news stories impacting Teleflex this week:

• Positive Sentiment: Teleflex announced a $250 million accelerated share repurchase agreement. The program should reduce the company’s share count and may support per-share earnings and investor sentiment. Teleflex Launches $250 Million Accelerated Share Repurchase
• Positive Sentiment: Second-quarter revenue rose 28.9% year over year to $570.3 million, exceeding the $559.6 million consensus estimate. Adjusted EPS of $1.76 also beat expectations of $1.28, providing evidence of better-than-expected operating performance. Teleflex Surpasses Q2 Earnings and Revenue Estimates
• Positive Sentiment: Teleflex raised or reaffirmed its fiscal 2026 adjusted EPS outlook at $6.90 to $7.20, above the $6.70 analyst consensus. Piper Sandler maintained an Overweight rating and increased its price target to $169 from $160, signaling additional potential upside. Piper Sandler Rating and Price Target
• Neutral Sentiment: Teleflex declared a quarterly dividend of $0.34 per share, payable September 30 to shareholders of record August 14. The dividend provides ongoing shareholder returns, though its approximately 1% yield is unlikely to be a major short-term catalyst.
• Negative Sentiment: GAAP diluted EPS from continuing operations fell to $0.96 from $1.54 a year earlier, while adjusted EPS declined from $3.73. Teleflex also reported a negative net margin, which may be weighing on the stock despite the quarterly earnings beat. Teleflex Reports Second Quarter Financial Results and Full Year 2026 Outlook

Institutional Trading of Teleflex

A number of institutional investors have recently bought and sold shares of the business. UMB Bank n.a. lifted its holdings in shares of Teleflex by 57.1% in the 4th quarter. UMB Bank n.a. now owns 311 shares of the medical technology company’s stock worth $38,000 after acquiring an additional 113 shares during the last quarter. Maryland State Retirement & Pension System grew its holdings in Teleflex by 1.5% during the 4th quarter. Maryland State Retirement & Pension System now owns 8,652 shares of the medical technology company’s stock valued at $1,056,000 after purchasing an additional 129 shares during the last quarter. Osaic Holdings Inc. raised its position in Teleflex by 17.5% in the 2nd quarter. Osaic Holdings Inc. now owns 1,247 shares of the medical technology company’s stock worth $148,000 after purchasing an additional 186 shares during the period. Vident Advisory LLC raised its position in Teleflex by 2.8% in the 4th quarter. Vident Advisory LLC now owns 6,992 shares of the medical technology company’s stock worth $853,000 after purchasing an additional 188 shares during the period. Finally, Empowered Funds LLC lifted its stake in Teleflex by 15.8% in the first quarter. Empowered Funds LLC now owns 1,684 shares of the medical technology company’s stock worth $233,000 after purchasing an additional 230 shares during the last quarter. Institutional investors own 95.62% of the company’s stock.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.